Clinical Trial Update: Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial of tezepelumab in adults with severe asthma has completed, with results posted evaluating its ability to reduce oral corticosteroid use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2025-12-11